View in a different locale / language
Eurofins Genomics has extensive experience in cutting-edge genomics research, molecular genetics and next generation sequencing (NGS) technology.
Next generation sequencing (NGS) has transformed genomic research by enabling massively parallel sequencing of millions of DNA fragments simultaneously. This powerful technology supports a wide range of applications, including whole-genome sequencing, targeted sequencing, RNA-Seq for gene expression analysis and novel transcript discovery, epigenetic studies such as DNA methylation analysis, investigation of DNA-protein interactions, microbiome profiling, and pathogen identification. By delivering high-throughput, accurate, and scalable genomic insights, NGS accelerates scientific discovery and advances research across diverse fields of life sciences.
Eurofins Genomics' NGS team enables researchers to perform a wide range of applications and address complex biological questions. We are committed to providing best-in-class NGS services that allow researchers to overcome technical hurdles and focus on scientific advancements. Our NGS services deliver exceptional sensitivity and reproducibility to support all your research needs.
At Eurofins Genomics, we ustilise advanced technologies from world-leading providers, enabling the generation of data from hundreds of samples in a single run and producing millions of individual DNA sequences per run. Over the years, our laboratory has optimised NGS processes and protocols to ensure the best possible scientific outcome for your research. We offer end-to-end services for your research needs (extraction, library preparation, sequencing and bioinformatics analysis) and also support our customers in designing their experiment and achieving the desired results.